Search by keywords: Connect with us Sloan Kettering @GSKGradSchool 521 News Items found Elizabeth Wasmuth Awarded 2015 Chairman’s Prize Monday, August 3, 2015 Gerstner Sloan Kettering student Elizabeth Wasmuth has been awarded the Chairman’s Prize for her paper published in Nature in 2014, on which she was the first author. Q&A Understanding the Body’s Immune Response to Inflammation Wednesday, July 15, 2015 Cell biologist Philipp Niethammer discusses what the zebrafish can teach us about how the body heals. In the Lab Manipulating a Single Gene Turns Colorectal Cancer Cells Back to Normal Wednesday, July 1, 2015 For the first time, scientists have shown that the gene APC, which is mutated in the vast majority of colorectal cancers, might be a promising target for future therapies. In the Lab Uncharted Waters: The Making of a New Cancer Drug Monday, June 22, 2015 A team of scientists is combining sophisticated chemistry and experiments in zebrafish to develop a new cancer drug that shows early potential against melanoma and metastatic breast cancer. Event Life Lessons: MSK Celebrates Distinguished Scientists and Young Scholars Wednesday, June 10, 2015 MSK’s Convocation and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences Commencement celebrate the achievements of young scientists. In the Lab Miniature Device Could Unlock the Promise of Some Kidney Cancer Drugs Monday, June 8, 2015 Memorial Sloan Kettering scientists have engineered a tiny particle that could ferry drugs directly to the kidneys and prevent their uptake in other organs. Our 2015 Summer Undergraduate Research Program Kicks Off Monday, June 1, 2015 We are thrilled to welcome 20 undergraduates to our ten-week course mentored by GSK’s outstanding faculty. Gerstner Sloan Kettering 2015 Candidates Successfully Defend Dissertations Friday, May 15, 2015 Three students have successfully defended their dissertations and will receive their PhD degrees at commencement on May 21. In the Lab Outsmarting Cancer’s Survival Skills Thursday, April 9, 2015 A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening. In the Clinic The Evolution of a Lifesaving Drug: A Scientist Reflects Thursday, March 12, 2015 Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer. Pagination First page « First Previous page ‹ Previous … Page 26 Page 27 Page 28 Page 29 Current page 30 Page 31 Page 32 Page 33 Page 34 … Next page Next › Last page Last »